REGULATION OF MAMMALIAN KERATINOUS TISSUE USING HEXAMIDINE COMPOSITIONS
First Claim
1. A skin care composition comprising:
- a) from about 0.02% to about 2.5% of a hexamidine compound;
b) from about 1% to about 5% of a vitamin B3 compound; and
c) a dermatologically acceptable carrier for the hexamidine and the skin care active, wherein said carrier is an emulsion.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to methods for regulating the condition of mammalian keratinous tissue wherein the methods each comprise the step of topically applying to the keratinous tissue of a mammal needing such treatment, a safe and effective amount of a skin care composition comprising:
- a) a safe and effective amount of a hexamidine compound selected from the group consisting of hexamidine, its salts, and derivatives;
- b) a safe and effective amount of one or more skin care active selected from the group consisting of sugar amine, vitamin B3, retinoid, peptide, phytosterol, butylated hydroxytoluene and butylated hydroxyanisole, their derivatives, and combinations thereof; and
- c) a dermatologically acceptable carrier for the hexamidine and the skin care active.
In additional embodiments, the above composition is suitable for preventing, retarding, and/or treating dark under-eye circles, puffy eyes, sagging, sallowness as well as spider vessels and/or red blotchiness of skin, promoting skin desquamation, exfoliation, and/or turnover, regulating and/or reducing pore size appearance, preventing/retarding tanning, regulating oily/shiny appearance, preventing, retarding, and/or treating hyperpigmentation in mammalian skin, preventing, retarding, and/or treating itchiness of mammalian skin, preventing, retarding, and/or treating dryness of skin, preventing, retarding, and/or treating fine lines and wrinkles, preventing, retarding, and/or treating skin atrophy of mammalian skin, softening and/or smoothing lips, hair and nails of a mammal, and preventing, retarding, and/or treating the appearance of cellulite in mammalian skin.
-
Citations
44 Claims
-
1. A skin care composition comprising:
-
a) from about 0.02% to about 2.5% of a hexamidine compound; b) from about 1% to about 5% of a vitamin B3 compound; and c) a dermatologically acceptable carrier for the hexamidine and the skin care active, wherein said carrier is an emulsion. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
-
30. A skin care composition comprising:
-
a) from about 0.02% to about 2.5% of a hexamidine compound; b) from about 1% to about 5% of a vitamin B3 compound; c) a panthenol compound; and d) a dermatologically acceptable carrier, wherein said carrier is an emulsion. - View Dependent Claims (31, 32, 33)
-
-
34. A skin care composition comprising:
-
a) from about 0.02% to about 1% of hexamidine diisethionate; b) from about 1% to about 5% of niacinamide; and c) a dermatologically acceptable carrier, wherein said carrier is an emulsion. - View Dependent Claims (35, 36, 37, 38, 39, 40, 44)
-
- 41. The skin care composition of claim 41 wherein the peptide is selected from a group consisting of dipeptides, tripeptides, tetrapeptides, pentapeptides, and combination thereof.
-
42. The skin care composition of claim 42 wherein the peptide is carnosine.
Specification